Navigation Links
Perrigo Reports Record Quarterly Revenue and Adjusted Earnings and Raises Full Year Adjusted EPS Guidance
Date:10/27/2011

Net cash from (for) operating activities54,147(6,162)Cash Flows (For) From Investing Activities   Acquisitions of businesses, net of cash acquired(547,052)1,998Proceeds from sale of intangible assets and pipeline R&D projects10,500-   Additions to property and equipment(18,953)(9,194)Other(250)-Net cash for investing activities(555,755)(7,196)Cash Flows (For) From Financing Activities   Borrowings (repayments) of short-term debt, net980(7,476)   Net borrowings under accounts receivable securitization program55,00063,000Borrowings of long-term debt250,787-   Repayments of long-term debt-(95,000)Deferred financing fees(2,468)-   Excess tax benefit of stock transactions10,5789,465   Issuance of common stock5,8843,987   Repurchase of common stock(7,899)(8,168)   Cash dividends(6,535)(5,780)Net cash from (for) financing activities306,327(39,972)Effect of exchange rate changes on cash1,792(337)Net decrease in cash and cash equivalents(193,489)(53,667)Cash and cash equivalents of continuing operations, beginning of period310,104109,765Cash balance of discontinued operations, beginning of period--Cash and cash equivalents, end of period116,61556,098Less cash balance of discontinued operations, end of period--Cash and cash equivalents of continuing operations, end of period

$

116,615$

56,098Supplemental Disclosures of Cash Flow Information   Cash paid/received during the period for:Interest paid

$

3,240$

6,343Interest received

$

1,127$

1,977Income taxes paid

$

9,151$

29,856Income taxes refunded

$

768$

893See accompanying notes to condensed consolidated financial statements.PERRIGO COMPANYCONDENSED CONSOLIDATED STATEMENTS OF INCOME(in thousands, except per share amounts)(unaudited)First Quarter20122011Net sales

$

725,295$

641,322Cost of sales497,716427,368Gross profit227,579213,954Operating expense
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
2. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
3. Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
4. Perrigo Confirms Filing for Generic Version of Mens Rogaine(R) Foam
5. Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
6. Perrigo Company Announces Dividend Increase
7. Perrigo Company Announces Quarterly Dividend
8. Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010
9. Perrigo Company to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Perrigo Company To Present at the Sidoti Emerging Growth Conference
11. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 The Galien Foundation today announced the ... USA Awards. The Prix Galien Award ... the technical, scientific and clinical research skills necessary to ... brings the highest number of nominees since the inception ... Nominees include biomedical products across three categories – biotechnology, ...
(Date:7/31/2014)... -- Genomic Health, Inc. (Nasdaq: GHDX ) today announced ... on Thursday, August 7 at 4:30 p.m. Eastern Time to ... webcast will follow the release of the second quarter financial ... access the live conference call on August 7 at 4:30 ... the United States and ...
(Date:7/31/2014)... , July 31, 2014  Celsion Corporation (NASDAQ: ... will host a conference call to discuss its second ... Thursday, August 7, 2014. To participate in the call, ... ) or 1-785-830-1924 (International/Toll) and ask for the ... 8283269) to register ten minutes before the call is ...
Breaking Medicine Technology:The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 2Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 3Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 4Celsion Corporation to Hold Second Quarter 2014 Financial Results 2
... On World COPD Day, Physicians Urged to Use Wider Screening Criteria ... Alpha-1 ... new study finds that a,higher than expected number of COPD and ... the need for broader,criteria for AAT deficiency testing. AAT deficiency, also ...
... with 200 mg/week mipomersen experienced 48% further reduction in LDL-cholesterol, ... ... Investor Day today - webcast live at 9:00 a.m. EST ... at http://www.isispharm.com , CARLSBAD, Calif., Nov. 13 Isis,Pharmaceuticals, ...
Cached Medicine Technology:Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease 2Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease 3Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease 4Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease 5Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary 2Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary 3Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary 4Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary 5Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary 6Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary 7
(Date:7/31/2014)... New York (PRWEB) July 31, 2014 ... is a major factor driving the global geriatric care ... demand outstrips the supply of these services across the ... family forming a home care agency to few large ... that the market is underserved and is also highly ...
(Date:7/31/2014)... During the winter of 1944, the Nazis blocked food ... widespread famine and devastation. The impact of starvation on ... "experiments" changes resulting from external rather than genetic ... to hardship could be inherited. The underlying mechanism, however, ... recently in the journal Cell , Dr. Oded ...
(Date:7/31/2014)... The “Nucleic Acid Isolation and Purification Market ... based), Consumables & Instruments, by Application (Plasmid DNA ... - Global Forecasts to 2018” provides a detailed ... current market trends, and strategies impacting the global ... the estimates and forecasts of the revenue and ...
(Date:7/31/2014)... Albany, NY (PRWEB) July 31, 2014 ... Review, H2 2014, provides an overview of the ... comprehensive information on the therapeutic development for Brain ... therapeutics assessment by drug target, mechanism of action ... along with latest updates, and featured news and ...
(Date:7/31/2014)... Calif., July 31, 2014 Much of the liver,s ... own body clock and UC Irvine researchers have ... , The study, published online today in Cell ... over metabolism and points the way to more focused ... as obesity and diabetes. , Paolo Sassone-Corsi, UCI,s Donald ...
Breaking Medicine News(10 mins):Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 2Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 3Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 4Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 5Health News:The 'memory' of starvation is in your genes 2Health News:The 'memory' of starvation is in your genes 3Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 2Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 3Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 4Health News:Strict genomic partitioning by biological clock separates key metabolic functions 2
... HealthDay Reporter , TUESDAY, Nov. 23 (HealthDay News) ... performance, but not necessarily in autistic children, a new ... spelling and math abilities of 30, "high-functioning" 9-year-old autistic ... parental and teacher reports at ages 6 and 9. ...
... cells (CSCs), the aggressive cells thought to be resistant to ... estrogen via a pathway that mirrors normal stem cell development. ... of breast CSCs, a finding that suggests a new drug ... the Proceedings of the National Academy of Sciences ...
... Exercising to music reduces the risk of falls among elderly ... adults, mostly women, average age 75.5 years, who were at ... intervention group that did a music-based multitask exercise program or ... six months, the participants switched groups for the next six ...
... , TUESDAY, Nov. 23 (HealthDay News) -- Implantable ... while preventing sudden death among heart failure patients ... real-world situations as they are in controlled study ... based on an analysis of nearly 186,000 patients ...
... the dangers of excessive fructose in diet. A new review ... of the American Society of Nephrology ( JASN ) ... Richard J. Johnson, MD and Takahiko Nakagawa, MD (Division ... concise overview of recent clinical and experimental studies to understand ...
... 22 (HealthDay News) -- Deaths from congenital heart defects in ... continuing a decades-long decline, a new study finds. Congenital ... These include a variety of conditions that range from mild ... as irregular heartbeats, congestive heart failure and high blood pressure ...
Cached Medicine News:Health News:For Autistic Kids, IQ May Not Predict School Achievement 2Health News:For Autistic Kids, IQ May Not Predict School Achievement 3Health News:Discovery halts breast cancer stem cells 2Health News:Practicing Moving to Music May Help Elderly Avoid Falls 2Health News: Implanted Heart Devices Have 'Real-World' Benefits: Study 2Health News: Implanted Heart Devices Have 'Real-World' Benefits: Study 3Health News:Deaths From Congenital Heart Defects on the Decline 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: